# Biom'Up Sas

- Location (FDA's records): St-Priest, FR
- FDA decisions: 2 (2011–2012): 2 510(k) clearances
- Product codes: JXI (1), NPL (1)
- Predicates its devices cite: 5 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Integra LifeSciences Corporation: 2 (https://510kreport.com/company/integra-lifesciences)
- Collagen Matrix, Inc.: 1 (https://510kreport.com/company/collagen-matrix)
- Ed. Geistlich Soehne AG Fuer Chemische Industrie: 1 (https://510kreport.com/company/ed-geistlich-soehne-ag-fuer-chemische-industrie)
- Colbar Lifescience, Ltd.: 1 (https://510kreport.com/company/colbar-lifescience)

## Firms that cite its devices most
- Toyobo Co., Ltd.: 1 (https://510kreport.com/company/toyobo)
- Monarch Bioimplants GmbH: 1 (https://510kreport.com/company/monarch-bioimplants)
- Biomup S.A.: 1 (https://510kreport.com/company/biomup)

## Its most-cited devices
- K103081: Covaortho-Nerve Resorbable Collagen Membrane (2012), cited by 3

## Recent decisions
- K103081: Covaortho-Nerve Resorbable Collagen Membrane (Mar 2, 2012)
- K103087: Covamax Resorbable Collagen Membrane (Aug 26, 2011)

Source page: https://510kreport.com/company/biom-up